American Association for Cancer Research

SHERPA: Unknown

People

  1. Moore
    Moore
  2. Overholtzer
    Overholtzer
  3. Ponomarev
    Ponomarev
  4. Jiang
    Jiang
  5. Danishefsky
    Danishefsky
  6. Drullinsky
    Drullinsky
  7. Finley
    Finley
  8. Scher
    Scher
  9. Wong
    Wong
  10. Bradbury
    Bradbury

Groups

  1. Cell Biology Program Faculty (54)
  2. Sloan Kettering Institute Faculty (54)
  3. GSK Faculty (19)
  4. Department of Medicine (14)
  5. Sloan Kettering Institute Postdocs (11)
  6. Molecular Pharmacology and Chemistry Program Faculty (10)
  7. Solid Tumor Oncology Division (10)
  8. Basic Research Innovation Award (BRIA) (9)
  9. Center for Hematologic Malignancies (9)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (9)
Search Within
  1. "Cell Biology Program Faculty"
Formats
  1. Meeting Abstract (29)
  2. Journal Article (25)
Groups
  1. Cell Biology Program Faculty (54)
  2. Sloan Kettering Institute Faculty (54)
  3. GSK Faculty (19)
  4. Department of Medicine (14)
  5. Sloan Kettering Institute Postdocs (11)
  6. Molecular Pharmacology and Chemistry Program Faculty (10)

More Groups

People
  1. Malcolm Moore (41)
  2. Jae-Hung Shieh (6)
  3. Kaida Wu (6)
  4. Michael Overholtzer (6)
  5. Ahmet Zehir (5)
  6. Server Ertem (5)

More People

Years
  1. 2025 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (3)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Cancer Research (44)
  2. Clinical Cancer Research (10)

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumorigenesis driven by BRAF(V600E) requires secondary mutations that overcome its feedback inhibition of RAC1 and migration
    Journal Article

    Gadal, S.; Boyer, J. A.; Roy, S. F.; Outmezguine, N. A.; Sharma, M.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; Barlas, A.; more...
    Cancer Research (2025)

    Fulltext@MSK | Save
  • Ultrasmall nanoparticle delivery of doxorubicin improves therapeutic index for high-grade glioma
    Journal Article

    Aragon-Sanabria, V.; Aditya, A.; Zhang, L.; Chen, F.; Yoo, B.; Cao, T.; Madajewski, B.; Lee, R.; Turker, M. Z.; Ma, K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Stem cell factor SOX2 confers ferroptosis resistance in lung cancer via upregulation of SLC7A11
    Journal Article

    Wang, X.; Chen, Y.; Wang, X.; Tian, H.; Wang, Y.; Jin, J.; Shan, Z.; Liu, Y.; Cai, Z.; Tong, X.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Cell identity determines TCA cycle dynamics
    Meeting Abstract

    Arnold, P. K.; Jackson, B. T.; Alibeckoff, S.; Drill, E.; Sullivan, L. B.; Finley, L. W. S.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Metabolic coordination of cancer cell fate
    Meeting Abstract

    Finley, L.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Ultrasmall core-shell silica nanoparticles for precision drug delivery in a high-grade malignant brain tumor model
    Journal Article

    Juthani, R.; Madajewski, B.; Yoo, B.; Zhang, L.; Chen, P. M.; Chen, F.; Turker, M. Z.; Ma, K.; Overholtzer, M.; Longo, V. A.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Tumor microenvironment derived NRG1 promotes antiandrogen resistance in prostate cancer
    Meeting Abstract

    Zhang, Z.; Karthaus, W.; Mota, J. M.; Mu, P.; Wu, C.; Abida, W.; Linton, E.; Lee, Y. S.; Lee, E.; Mao, N.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • CD31 expression determines redox status and chemoresistance in human angiosarcomas
    Journal Article

    Venkataramani, V.; Küffer, S.; Cheung, K. C. P.; Jiang, X.; Trümper, L.; Wulf, G. G.; Ströbel, P.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Stereochemistry matters: L-2HG as a tumor response to hypoxia
    Meeting Abstract

    Thompson, C. B.; Intlekofer, A. M.; DeMatteo, R. G.; Venneti, S.; Finley, L. W. S.; Lu, C.; Rustenburg, A. S.; Grinaway, P. B.; Chodera, J. D.; Cross, J. R.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Ureidomustine, a novel DNA-crosslinking agent shows activity in sarcoma preclinical models and lacks toxicity in normal tissues
    Meeting Abstract

    Ambati, S. R.; Shieh, J.; Pera, B.; Wong, E. W. P.; Lopes, E. C.; Peguero, E.; Su, T. L.; Moore, M. A. S.
    Cancer Research (2015)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: